Single-cell Analysis Global Market Report 2026

Single-cell analysis involves the study of transcriptomics, genomics, proteomics, cell interactions, and metabolomics at the individual cell level. This field aids in standardizing and automating workflows to gather information crucial for treating various diseases, including cancer. Activities in single-cell analysis revolve around research and experimental development in this specialized area.

The primary categories of single-cell analysis include consumables and instruments. Consumables are employed in tasks such as exosome analysis, genetic exploration, and isolation of RNA and DNA. The workflow of single-cell analysis comprises single-cell isolation and library preparation, downstream analysis, and data analysis. Techniques utilized in this process encompass flow cytometry, next-generation sequencing, polymerase chain reaction (PCR), microscopy, mass spectrometry, among others. Single-cell analysis finds applications in diverse areas such as cancer research, immunology, neurology, stem cell studies, non-invasive prenatal diagnosis, in-vitro fertilization, and more. The end-users of single-cell analysis include academic and research laboratories, biotechnology and pharmaceutical companies, as well as hospital and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the single-cell analysis market by increasing costs of imported reagents, microfluidic chips, sequencing instruments, and analytical software components. Research institutions in North America and Europe are most affected due to reliance on specialized imported consumables, while Asia-Pacific faces cost pressure on equipment procurement. These tariffs are elevating research costs and extending procurement cycles. However, they are also encouraging regional manufacturing of consumables and localized development of analytical platforms.

The single-cell analysis market research report is one of a series of new reports from The Business Research Company that provides single-cell analysis market statistics, including single-cell analysis industry global market size, regional shares, competitors with a single-cell analysis market share, detailed single-cell analysis market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell analysis industry. This single-cell analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-cell analysis market size has grown rapidly in recent years. It will grow from $3.93 billion in 2025 to $4.54 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to advancements in genomic research tools, expansion of cancer research programs, increasing funding for life sciences research, growing adoption of next generation sequencing, rising academic research activities.

The single-cell analysis market size is expected to see rapid growth in the next few years. It will grow to $8.21 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing investments in precision medicine, expansion of single-cell applications in drug discovery, rising use in clinical research, growing adoption of ai-driven biological analysis, increasing demand for personalized therapeutics. Major trends in the forecast period include increasing adoption of high-throughput single-cell sequencing, rising integration of multi-omics analysis, growing use of ai in cell data interpretation, expansion of automated single-cell workflows, enhanced focus on translational research.

The rising emphasis on personalized medicine worldwide is driving the expansion of the single-cell analysis market. Personalized medicine is a medical approach that utilizes an individual's genetic profile to inform decisions regarding the treatment, prevention, and diagnosis of diseases specific to that person. Single-cell analysis plays a crucial role in treating various conditions by providing detailed insights into individual patient needs, the nature of the disease, and tailored treatment options. As a result, more patients are choosing personalized medicine for their care. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Consequently, the growing focus on personalized medicine is fueling market growth.

Leading companies in the single-cell analysis field are focusing on developing advanced clinical diagnostic tools, such as high-precision single-cell RNA-sequencing kits, to enhance the accuracy and depth of gene-expression analysis. High-precision single-cell RNA-sequencing kits are specialized instruments designed to precisely capture and examine gene expression at the level of individual cells, enabling researchers to reveal cellular diversity, detect rare cell types, and gain deeper understanding of biological processes and disease mechanisms. For example, in June 2024, Bio-Rad, a US-based global leader in life science research and clinical diagnostics, launched the Single-Cell 3' RNA-Seq Kit for single-cell gene expression. This kit is specifically designed for high-throughput sequencing of gene expression from individual cells, targeting the 3' end of mRNA transcripts, which allows researchers to analyze and quantify gene expression profiles in single cells. It is extensively used in studies of cellular heterogeneity, developmental biology, and disease mechanisms, providing valuable insights into complex biological systems and driving advancements in single-cell analysis.

In July 2023, Illumina, Inc., a US-based biotechnology company, acquired Fluent BioSciences for an undisclosed amount. The purpose of this acquisition is to enhance Illumina's capabilities in single-cell analysis and expand its multiomics growth strategy by integrating Fluent BioSciences' innovative and accessible technology. Fluent BioSciences, also based in the US, focuses on advancing technologies for single-cell analysis, with a particular emphasis on creating scalable and innovative solutions that facilitate genomic research and enable researchers to conduct detailed studies at the single-cell level.

Major companies operating in the single-cell analysis market include Becton Dickinson and Company, Merck KGAA, QIAGEN N. V., Thermo Fisher Scientific Inc., Illumina Inc., Standard BioTools Inc., 10X Genomics Inc., Bio-Rad Laboratories Inc., Novogene Corporation Limited, Agilent Technologies Inc., Sartorius AG, Luminex Corporation, Fluxion Biosciences Inc., Oxford Nanopore Technologies Ltd., 1CellBio Inc., 3D Biomatrix Inc., ACEA Biosciences Inc., Akoya Biosciences Inc., Berkeley Lights Inc., Bio-Techne Corporation, Celsee Inc., Cellular Research Inc., Cytena GmbH, Dolomite Bio Limited, Drop-seq Technologies Inc., Epic Sciences Inc., Ginkgo Bioworks Inc., IsoPlexis Corporation, Menarini Silicon Biosystems S. p. A., Mission Bio Inc., NanoCellect Biomedical Inc., NemaMetrix Inc., OnRamp Bioinformatics Inc., Partek Incorporated, RareCyte Inc., Scienion AG, SeqWell Inc., Sphere Fluidics Limited, Takara Bio USA Holdings Inc.

North America was the largest region in the single-cell analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the single-cell analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The single-cell analysis market includes revenues earned by entities by providing services such as antibody-based methods, fluorescent protein-based methods, and mass-spectroscopy based methods. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-cell Analysis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses single-cell analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single-cell analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-cell analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Consumables; Instruments
• 2) By Workflow: Single-Cell Isolation And Library Preparation; Downstream Analysis; Data Analysis
• 3) By Technique: Flow Cytometry; Next Generation Sequencing; Polymerase Chain Reaction (PCR); Microscopy; Mass Spectrometry; Other Techniques
• 4) By Application: Cancer; Immunology; Neurology; Stem Cell; Non-invasive prenatal diagnosis; In-Vitro fertilization; Other Applications
• 5) By End User: Academic and Research Laboratories; Biotechnology And Pharmaceutical Companies; Hospital And Diagnostic Laboratories
• Subsegments:
• 1) By Consumables: Reagents; Kits; Assay Plates And Containers; Microfluidic Chips
• 2) By Instruments: Flow Cytometers; Cell Sorters; Microscopes; Imaging Systems; Single-Cell Sequencers
• Companies Mentioned: Becton Dickinson and Company; Merck KGAA; QIAGEN N. V.; Thermo Fisher Scientific Inc.; Illumina Inc.; Standard BioTools Inc.; 10X Genomics Inc.; Bio-Rad Laboratories Inc.; Novogene Corporation Limited; Agilent Technologies Inc.; Sartorius AG; Luminex Corporation; Fluxion Biosciences Inc.; Oxford Nanopore Technologies Ltd.; 1CellBio Inc.; 3D Biomatrix Inc.; ACEA Biosciences Inc.; Akoya Biosciences Inc.; Berkeley Lights Inc.; Bio-Techne Corporation; Celsee Inc.; Cellular Research Inc.; Cytena GmbH; Dolomite Bio Limited; Drop-seq Technologies Inc.; Epic Sciences Inc.; Ginkgo Bioworks Inc.; IsoPlexis Corporation; Menarini Silicon Biosystems S. p. A.; Mission Bio Inc.; NanoCellect Biomedical Inc.; NemaMetrix Inc.; OnRamp Bioinformatics Inc.; Partek Incorporated; RareCyte Inc.; Scienion AG; SeqWell Inc.; Sphere Fluidics Limited; Takara Bio USA Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.